News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Woman Accused of Fatal Accident Wants New Attorney

ANDREA LITTLE 102052

Andrea Little had been expected to plead guilty.

in Local

Federal Grand Jury Indicts 2 Decatur Residents

jail

Two Decatur residents have been charged by a federal grand jury in Springfield.

in Local

House Fails to Override Veto of Union-Backed Bill

rauner

The House voted 68-34 to override Rauner's veto of the bill. It needed 71 votes to become law.

in Local

Child Care Assistance Program Changes Fail By One Vote

local_news_generic

A plan to restore state-subsidized child care assistance for low-income working parents has failed by one vote in the Illinois House.

in Local

Peoria Settles With Man Who Parodied Mayor on Twitter

twitter

The city of Peoria will pay $125,000 to a man whose home was raided after he created a Twitter account to parody the mayor.